Pharm'Up
A new study published in the Journal of the American Heart Association reveals that maintaining optimal cardiovascular...
In a critical move to combat a potential new front in the opioid crisis, the FDA has...
A recent study from Mass General Brigham investigators has revealed that an investigational drug, larazotide, which was...
August marks National Immunization Awareness Month (NIAM), a crucial time for pharmacists to step into a leading...
In a significant development for patients with a devastating and rare brain cancer, the U.S. Food and...
A recent study published in Scientific Reports is challenging long-held assumptions about the effects of caffeine on...
The One Big Beautiful Bill Act (OBBBA), signed by President Donald J. Trump in July 2025, contains...
The Trump administration’s new tax law, the “One Big Beautiful Bill Act” (OBBB), has stirred significant debate...
A new review and meta-analysis published in Frontiers in Pharmacology indicates that inclisiran (Leqvio), a novel small...
The Department of Health and Human Services (HHS), under the direction of Secretary Robert F. Kennedy Jr.,...
